Proteomic analysis of microglial contribution to mouse strain-dependent dopaminergic neurotoxicity
Proteomic analysis of microglial contribution to mouse strain-dependent dopaminergic neurotoxicity
复制标题
作者:
Mclaughlin, P;Zhou, Y;Zhang, J
Although the pathogenesis of Parkinson's disease (PD) remains unknown, it appears that microglial activation is associated with enhanced neurodegeneration in animal models of PD as well as in PD patients. Experimentally, C57BL/6 and SWR/J mice demonstrate striking differences in the extent of dopaminergic (DAergic) neurodegeneration induced by a parkinsonian toxicant 1-methyl-4-phenyl.2,3,6-tetrahydropyridine (MPTP). The purpose of this study was to determine whether differences in microglial activation between these two strains of mice could provide insight into the variability seen in toxicant induced neuronal death, and subsequently to use a high-throughput proteomic method, combining stable isotope labeling with amino acids in cell culture (SILAC) with liquid chromatography and tandem mass spectrometry, to compare the microglial proteomes of C57BL/6 and SWR/J mice after stimulation with a classical microglial activator, lipopolysaccharide (LIPS). We found that DAergic neurotoxicity induced by LPS in a primary neuron-microglia coculture was two old greater with microglia isolated from the brains of C57BL/6 mice compared with that of SWR/J mice. Upon proteomic analysis we found that, out of over 1000 proteins dentified and quantified, 400 displayed a significant difference in their relative abundance between these two murine;trains. Several proteins, which had relatively higher levels n C57BL/6 mice, have previously been implicated in LPS-mediated microglial activation, including those involved in;he COX-2 pathway and in prostaglandin E-2 (PGE(2)) production. To validate our proteomic results we confirmed the increased expression level of iNOS in C57BL/6 vs. SWR/J microglia with semiquantitative Western blot. Further analysis of our proteomic discovery data will likely reveal numerous novel proteins involved in inflammation-mediated neurotoxicity in PD. (c) 2006 Wiley-Liss, Inc.